Allogene Therapeutics Inc (NASDAQ: ALLO) is -12.77% lower on its value in year-to-date trading and has touched a low of $2.01 and a high of $5.78 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ALLO stock was last observed hovering at around $2.68 in the last trading session, with the day’s gains setting it 0.12%.
Currently trading at $2.80, the stock is 4.44% and 3.95% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.28 million and changing 4.48% at the moment leaves the stock -12.26% off its SMA200. ALLO registered 10.67% gain for a year compared to 6-month gain of 1.45%. The firm has a 50-day simple moving average (SMA 50) of $2.6936 and a 200-day simple moving average (SMA200) of $3.1912.
The stock witnessed a 0.00% loss in the last 1 month and extending the period to 3 months gives it a -4.76%, and is 0.00% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.19% over the week and 6.73% over the month.
Allogene Therapeutics Inc (ALLO) has around 233 employees, a market worth around $585.51M and $0.09M in sales. Profit margin for the company is -323780.23%. Distance from 52-week low is 39.30% and -51.52% from its 52-week high. The company has generated returns on investments over the last 12 months (-46.25%).
with sales reaching $10k over the same period.The EPS is expected to grow by 33.75% this year, but quarterly earnings will post -36.80% year-over-year.
Allogene Therapeutics Inc (ALLO) Top Institutional Holders
242.0 institutions hold shares in Allogene Therapeutics Inc (ALLO), with institutional investors hold 101.52% of the company’s shares. The shares outstanding are 167.13M, and float is at 138.06M with Short Float at 28.48%. Institutions hold 83.78% of the Float.
The top institutional shareholder in the company is FMR LLC with over 31.26 million shares valued at $72.83 million. The investor’s holdings represent 18.4816% of the ALLO Shares outstanding. As of 2024-06-30, the second largest holder is TPG GP A, LLC with 18.72 million shares valued at $43.61 million to account for 11.0663 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 16.45 million shares representing 9.7238% and valued at over $38.32 million, while VANGUARD GROUP INC holds 4.8458 of the shares totaling 8.2 million with a market value of $19.1 million.
Allogene Therapeutics Inc (ALLO) Insider Activity
#####
Still, SEC filings show that on Jun 18 ’24, MESSEMER DEBORAH M. (Director) disposed off 18,641 shares at an average price of $2.28 for $42488.0. The insider now directly holds 166,765 shares of Allogene Therapeutics Inc (ALLO).
